Skip to main content

Table 1 Differences in patient characteristics between participants and non participants in a RCT-trial on adherence

From: Prior medication adherence of participants and non participants of a randomized controlled trial to improve patient adherence in cardiovascular risk management

 

Participants [n = 419]

Non-participants [n = 481]

P-value

Age [mean, ±SD)

60.5 [±10]

63 [11]

0.001

Gender (N [%])

 Male

296 [7]

279 [58]

< 0.001

 Female

123 [29

202 [42]

Education level (N[%])

< 0.001

 Primary

66 [18]

141 [31]

 

 Secondary

185 [49]

180 [39]

 University

124 [33]

140 [30]

Labour (N[%])

0.08

 Paid labour

137 [37]

123 [27]

 

 Unemployed

98 [26.3]

138 [30]

 Retired

138 [37]

199 [43.3]

Country of origin is the Netherland (N[%])

0.66

 Yes

327 [90]

398 [86]

 No

37 [10]

64 [14]

Reason referral (N[%])

< 0.001

 acute coronary syndrome

150 [36]

79 [16]

 peripheral arterial disease

71 [17]

101 [21]

 troke/TIA

198 [47]

301 [63]

Blood pressure (mmHg; mean ± SD)

< 0.001

 Systolic

136 [±18]

142 [±20]

0.23

 Diastolic

77 [±11]

78 [±11]

Body Mass Index (mean ± SD)

27 [±4]

26 [±4]

0.30

Waist (mean ± SD)

 Male

99.5 [±9]

98.4 [±12]

0.10

 Female

92 [±14]

90 [±13]

0.07

Lipids (mmol/ltr, mean SD)

 Totaal cholesterol

4.5 [±1.1]

4.6 [±1]

0.7

 Triglyceriden

1.8 [±1]

1.7 [±1]

0.01

 HDL

1.2 [±0.3]

1.2 [±0.3]

0.002

 LDL

2.5 [±0.9]

2.6 [±0.9]

0.66

Medication (N [%])

 Antithrombotic agents [ATC B01]

404 [98]

461 [98]

0.78

 Diuretics [ATC C03]

109 [26]

135 [29]

0.44

 Beta Blocking agents [ATC C07]

239 [58]

218 [46]

0.001

 Calcium channel blockers [ATCC08]

65 [16]

72 [15]

0.86

 Agents acting on [..] system [ATC C09]

244 [59]

206 [44]

0.001

 Lipid modifying agents [ATC C10]

387 [94]

384 [82]

< 0.001